The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review
Cancer Treatment Reviews · 2025-03 · 134 · 102899
DOI: 10.1016/j.ctrv.2025.102899 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2025-03. Verfasst von Giulia Arrivi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit Department of Clinical and Molecular Medicine Sapienza University of Rome Sant'Andrea University Hospital ENETS Center of Excellence Ro…. Hauptthemen laut MEDLINE: Streptozocin, Pancreatic Neoplasms, Neuroendocrine Tumors, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Pancreatic neuroendocrine tumors (pan-NETs) represent a highly heterogeneous and complex pathology, with therapeutic management and prognosis influenced by several biological and clinical characteristics. Chemotherapy, including regimens based on capecitabine and temozolomide (CAPTEM) or the combination of streptozotocin and 5-fluorouracil (STZ-5FU), is indicated for rapidly growing, symptomatic, or high-burden disease requiring swift cytoreduction. Historical studies provide scientific evidence for the STZ-5FU regimen, often retrospective and frequently analyzing small series. Despite these limitations, the efficacy of this treatment is well-established, and it is included in all guidelines as a therapeutic option. This systematic review aims to gather scientific evidence on using STZ-based chemotherapy to assess its real impact in managing well-differentiated metastatic or unresectable pan-NETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Unit Department of Clinical and Molecular Medicine Sapienza University of Rome Sant'Andrea University Hospital ENETS Center of Excellence Rome Italy.
- Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS Milan IT Italy.
- Sarcomas and Rare Tumors Unit, Istituto Nazionale Tumori, IRCCS Fondazione "G. Pascale", Naples 80131, Italy.
- Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, "Vita-Salute" San Raffaele University, Milan, Italy.
- Medical Oncology Unit, Humanitas Istituto Clinico Catanese, Misterbianco, Catania 95045, Italy.
- Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Zitieren
APA
Arrivi, G., Fazio, N., Tafuto, S., Falconi, M., Carnaghi, C., Campana, D., Rinzivillo, M., & Panzuto, F. (2025). The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review. Cancer Treatment Reviews, 134, 102899. https://doi.org/10.1016/j.ctrv.2025.102899
Vancouver
Arrivi G, Fazio N, Tafuto S, Falconi M, Carnaghi C, Campana D, et al. The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review. Cancer Treatment Reviews. 2025;134:102899. doi:10.1016/j.ctrv.2025.102899
BibTeX
@article{Arrivi2025,
author = {Arrivi, Giulia and Fazio, Nicola and Tafuto, Salvatore and Falconi, Massimo and Carnaghi, Carlo and Campana, Davide and Rinzivillo, Maria and Panzuto, Francesco},
title = {The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {134},
pages = {102899},
doi = {10.1016/j.ctrv.2025.102899}
}
EUVIMED